Detection and quantitation of N′-nitrosonornicotine in human toenails by liquid chromatography-electrospray ionization-tandem mass spectrometry

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 4, 2008, Pages 945-948

  Stepanov, Irina ^a   Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHEMICAL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SMOKING;

BIOLOGICAL MARKERS; CARCINOGENS; CHROMATOGRAPHY, LIQUID; HUMANS; NAILS; NICOTINE; NITROSAMINES; PYRIDINES; TANDEM MASS SPECTROMETRY;

EID: 42149172331     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2711     Document Type: Article

References (24)

1. Hecht SS. Tobacco carcinogens, their biomarkers, and tobacco-induced cancer. Nat Rev Cancer 2003;3:733-44.
2. Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 2002;23:907-22.
3. Carmella SG, Akerkar S, Richie JP, Jr., et al. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol Biomarkers Prev 1995;4:635-42.
4. Anderson KE, Carmella SG, Ye M, et al.Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke in their homes. J Natl Cancer Inst 2001;93:378-81.
5. Hecht SS, Ye M, Carmella SG, et al. Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. Cancer Epidemiol Biomarkers Prev 2001;10:1109-16.
6. Hecht SS, Carmella SG, Chen M, et al. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res 1999;59:590-6.
7. Hecht SS, Carmella SG, Ye M, et al. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use. Cancer Res 2002;62:129-34.
8. Stepanov I, Feuer R, Jensen J, et al. Mass spectrometric quantitation of nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human toenails. Cancer Epidemiol Biomarkers Prev 2006;15:2378-83.
9. Stepanov I, Hecht SS, Lindgren B, et al. Relationship of human toenail nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol to levels of these biomarkers in plasma and urine. Cancer Epidemiol Biomarkers Prev 2007;16:1382-6.
10. Palmeri A, Pichini S, Pacifici R, et al. Drugs in nails. Physiology, pharmacokinetics and forensic toxicology. Clin Pharmacokinet 2000;38:95-110.
11. Stepanov I, Hecht SS. Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users. Cancer Epidemiol Biomarkers Prev 2005;14:885-91.
12. Hecht SS, Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 1988;9:875-84.
13. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998;11:559-603.
14. Spiegelhalder B, Bartsch H. Tobacco-specific nitrosamines. Eur J Cancer Prev 1996;5:33-8.
15. Hecht SS, Hoffmann D. The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv 1989;8:273-94.
16. Porubin D, Hecht SS, Li Z, et al. Endogenous formation of N′-nitrosonornicotine in F344 rats in the presence of some antioxidants and grape seed extract. J Agric Food Chem 2007;55:7199-204.
17. Adams JD, LaVoie EJ, O'Donnell M, et al. Pharmacokinetics of tobacco-specific N-nitrosamines. IARC Sci Publ 1984;57:779-85.
18. Adams JD, LaVoie EJ, Hoffmann D. On the pharmacokinetics of tobacco-specific N-nitrosamines in Fischer rats. Carcinogenesis 1985;6:509-11.
19. Adams JD, LaVoie EJ, O'Mara-Adams KJ, et al. A study of tobacco carcinogenesis XXIX. Pharmacokinetics of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in laboratory animals. Cancer Let 1985;28:195-201.
20. Upadhyaya P, Zimmerman CL, Hecht SS. Metabolism and pharmacokinetics of N′-nitrosonornicotine in the patas monkey. Drug Metab Dispos 2002;30:1115-22.
21. Hecht SS, Trushin N, Reid-Quinn CA, et al. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites. Carcinogenesis 1993;14:229-36.
22. Faergemann J, Laufen H. Levels of fluconazole in normal and diseased nails during and after treatment of onychomycoses in toe-nails with fluconazole 150mg once weekly. Acta Derm Venereol 1996;76:219-21.
23. Garside D, Ropero-Miller JD, Goldberger BA, et al. Identification of cocaine analytes in fingernail and toenail specimens. J Forensic Sci 1998;43:974-9.
24. Al-Delaimy WK, Mahoney GN, Speizer FE, et al. Toenail nicotine levels as biomarker of tobacco smoke exposure. Cancer Epidemiol Biomarkers Prev 2002;11:1400-4.